Avrobio
Latest round
- Series B
Last raised
- Feb 2018
Total raised
- $85M
Investors
- 9
About Avrobio
Founded in 2015 and based in Massachusetts, US, Avrobio, Inc. operates as a biopharmaceutical company that develops and manufactures cell and gene therapies for the treatment of cancer and rare diseases.
Who invested in Avrobio
9 investors across 3 rounds
See all investors in Avrobio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avrobio
Who invested in Avrobio?
Avrobio has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avrobio raised?
Avrobio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Avrobio last raise money?
Avrobio's most recent round on record is a Series B, in Feb 2018.
What does Avrobio do?
Founded in 2015 and based in Massachusetts, US, Avrobio, Inc.
Where is Avrobio headquartered?
Avrobio is headquartered in Cambridge, US.
Which VCs invest in companies like Avrobio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avrobio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Avrobio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.